Needle-Free Epinephrine Options Are On The Horizon

Tonya Winders, CEO and president of the Allergy & Asthma Network, a nonprofit education and advocacy organization, has a teenager with food allergies. “I know the angst it causes her to have that constant reminder that every time she eats, she could be at risk for anaphylaxis,” she says, “not to mention inconvenience, the size of it, the fear of the needle.”

Research shows that many people feel much the same way.

In a survey of more than 1,200 families whose children were prescribed epinephrine auto-injectors for peanut allergies, more than half the parents said they were afraid to use the devices. A review of anaphylaxis cases around the globe found that less than a quarter of children and just 7% of adults with anaphylaxis got epinephrine before going to the hospital – again, underscoring the underuse of this lifesaving medication.
This data is concerning because a delay in getting epinephrine is associated with a higher risk of dying from anaphylaxis.

At the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, held February 25-28 virtually and in Phoenix, AZ, researchers discussed barriers to epinephrine use and presented new data on needle-free epinephrine products, which could become available next year.

Click Here For The Full Article: Needle-Free Epinephrine Options Are On The Horizon